What do studies say about Triglyceride Basis?

The genetic basis of triglyceride levels is most strongly studied via the rs662799 polymorphism in the APOA5 gene. The G allele is associated with higher triglycerides (OR ~1.86, p=9e-150), representing a robust GWAS signal. However, the effect size is modest and explains only a small fraction of interindividual variation. Evidence comes from large-scale association studies, not interventional trials. Actual triglyceride levels are heavily influenced by diet (sugar, fat, alcohol), physical activity, body weight, and medications. A DNA test alone cannot diagnose hypertriglyceridemia; a fasting blood lipid panel is required. The clinical utility of rs662799 is moderate: carriers of the G allele have increased risk, but lifestyle modifications can substantially mitigate this. Caveat: the association is not proven causal, and findings are primarily based on European-ancestry cohorts. For personalized risk assessment, family history, blood biomarkers, and medical consultation are essential.